Federation des caisses Desjardins du Quebec’s Arcturus Therapeutics ARCT Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58K	Hold	235	–	–	﹤0.01%	2768
2026 Q1	$1.81K	Hold	235	–	–	﹤0.01%	2686
2025 Q4	$1.44K	Hold	235	–	–	﹤0.01%	2640
2025 Q3	$4.33K	Hold	235	–	–	﹤0.01%	2490
2025 Q2	$3.06K	Hold	235	–	–	﹤0.01%	2348
2025 Q1	$2.49K	Sell	235 -10	-4%	-$159	﹤0.01%	2303
2024 Q4	$4.16K	Hold	245	–	–	﹤0.01%	2129
2024 Q3	$5.69K	Buy	245 +95	+63%	+$2.03K	﹤0.01%	2042
2024 Q2	$3.65K	Hold	150	–	–	﹤0.01%	2020
2024 Q1	$5.07K	Buy	150 +140	+1,400%	+$4.96K	﹤0.01%	1958
2023 Q4	$315	Hold	10	–	–	﹤0.01%	2234
2023 Q3	$256	Hold	10	–	–	﹤0.01%	2259
2023 Q2	$287	Buy	+10	New	+$272	﹤0.01%	2227

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ARCT Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Arcturus Therapeutics (ARCT) position steady in Q2 2026 at 235 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2768.

Federation des caisses Desjardins du Quebec first reported a position in ARCT in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.69K in Q3 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

Federation des caisses Desjardins du Quebec held 235 shares of Arcturus Therapeutics worth $1.58K as of Q2 2026.
Federation des caisses Desjardins du Quebec left its Arcturus Therapeutics share count unchanged in Q2 2026.
Arcturus Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2768 holding.
Federation des caisses Desjardins du Quebec first reported a position in Arcturus Therapeutics in Q2 2023 and has held it in 13 quarters since.
Federation des caisses Desjardins du Quebec's Arcturus Therapeutics position peaked at $5.69K in Q3 2024.
135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.